782041008: Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product\...

\Medicinal product categorised by disposition\Enzyme inhibitor-containing product\Hydrolase inhibitor-containing product\Phosphodiesterase inhibitor-containing product\Papaveretum-containing product\Hyoscine- and papaveretum-containing product\Hyoscine and papaveretum only product\Hyoscine and papaveretum only product in parenteral dose form\Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection
\Medicinal product categorised by disposition\Enzyme inhibitor-containing product\Hydrolase inhibitor-containing product\Phosphodiesterase inhibitor-containing product\Papaveretum-containing product\Hyoscine- and papaveretum-containing product\Hyoscine- and papaveretum-containing product in parenteral dose form\Hyoscine and papaveretum only product in parenteral dose form\Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection
\Medicinal product categorised by disposition\Opioid receptor agonist-containing product\Papaveretum-containing product\Hyoscine- and papaveretum-containing product\Hyoscine and papaveretum only product\Hyoscine and papaveretum only product in parenteral dose form\Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection
\Medicinal product categorised by disposition\Opioid receptor agonist-containing product\Papaveretum-containing product\Hyoscine- and papaveretum-containing product\Hyoscine- and papaveretum-containing product in parenteral dose form\Hyoscine and papaveretum only product in parenteral dose form\Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection
\Medicinal product categorised by disposition\Acetylcholine receptor antagonist-containing product\Muscarinic receptor antagonist-containing product\Hyoscine-containing product\Hyoscine- and papaveretum-containing product\Hyoscine and papaveretum only product\Hyoscine and papaveretum only product in parenteral dose form\Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection
\Medicinal product categorised by disposition\Acetylcholine receptor antagonist-containing product\Muscarinic receptor antagonist-containing product\Hyoscine-containing product\Hyoscine- and papaveretum-containing product\Hyoscine- and papaveretum-containing product in parenteral dose form\Hyoscine and papaveretum only product in parenteral dose form\Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection
\Medicinal product categorised by disposition\Acetylcholine receptor antagonist-containing product\Muscarinic receptor antagonist-containing product\Hyoscine-containing product\Hyoscine-containing product in parenteral dose form\Hyoscine- and papaveretum-containing product in parenteral dose form\Hyoscine and papaveretum only product in parenteral dose form\Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection

\Medicinal product categorised by structure\Alkaloid-containing product\...

\Opium alkaloid-containing product\Papaveretum-containing product\Hyoscine- and papaveretum-containing product\...

\Hyoscine and papaveretum only product\Hyoscine and papaveretum only product in parenteral dose form\Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection

\Hyoscine- and papaveretum-containing product in parenteral dose form\Hyoscine and papaveretum only product in parenteral dose form\Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection

\Hyoscine-containing product\Hyoscine- and papaveretum-containing product\Hyoscine and papaveretum only product\Hyoscine and papaveretum only product in parenteral dose form\Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection
\Hyoscine-containing product\Hyoscine- and papaveretum-containing product\Hyoscine- and papaveretum-containing product in parenteral dose form\Hyoscine and papaveretum only product in parenteral dose form\Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection
\Hyoscine-containing product\Hyoscine-containing product in parenteral dose form\Hyoscine- and papaveretum-containing product in parenteral dose form\Hyoscine and papaveretum only product in parenteral dose form\Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection

\Product manufactured as parenteral dose form\Hyoscine-containing product in parenteral dose form\Hyoscine- and papaveretum-containing product in parenteral dose form\Hyoscine and papaveretum only product in parenteral dose form\Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection

\Autonomic agent\Acetylcholine receptor antagonist-containing product\Muscarinic receptor antagonist-containing product\Hyoscine-containing product\...

\Hyoscine- and papaveretum-containing product\Hyoscine and papaveretum only product\Hyoscine and papaveretum only product in parenteral dose form\Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection
\Hyoscine- and papaveretum-containing product\Hyoscine- and papaveretum-containing product in parenteral dose form\Hyoscine and papaveretum only product in parenteral dose form\Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection

\Hyoscine-containing product in parenteral dose form\Hyoscine- and papaveretum-containing product in parenteral dose form\Hyoscine and papaveretum only product in parenteral dose form\Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection

Status: current, Defined. Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3752376017 Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug) en Fully specified name Active Case insensitive SNOMED CT core

3752377014 Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection en Synonym Active Initial character case insensitive SNOMED CT core

3752378016 Papaveretum 15.4 mg/mL and scopolamine hydrobromide 400 microgram/mL solution for injection en Synonym Active Initial character case insensitive SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	Has concentration strength denominator value	1	false	Inferred relationship	Some	2
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	Has concentration strength numerator value	15.4	false	Inferred relationship	Some	1
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	Has concentration strength numerator unit	mcg	false	Inferred relationship	Some	2
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	Has concentration strength denominator unit	mL	true	Inferred relationship	Some	2
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	Has manufactured dose form	Solution for injection	true	Inferred relationship	Some
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	Count of base of active ingredient	2	false	Inferred relationship	Some
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	Has concentration strength denominator unit	mL	true	Inferred relationship	Some	1
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	Has concentration strength denominator value	1	false	Inferred relationship	Some	1
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	Has concentration strength numerator unit	mg	false	Inferred relationship	Some	1
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	Has BoSS	Hyoscine hydrobromide	false	Inferred relationship	Some	2
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	Has BoSS	Papaveretum	false	Inferred relationship	Some	1
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	Has precise active ingredient	Hyoscine hydrobromide	false	Inferred relationship	Some	2
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	Is a	Hyoscine and papaveretum only product in parenteral dose form	true	Inferred relationship	Some
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	Has concentration strength numerator value	400	false	Inferred relationship	Some	2
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	Has precise active ingredient	Papaveretum	false	Inferred relationship	Some	1
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	Has BoSS	Hyoscine hydrobromide	true	Inferred relationship	Some	1
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	Has precise active ingredient	Papaveretum	true	Inferred relationship	Some	2
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	Has concentration strength numerator unit	mcg	true	Inferred relationship	Some	1
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	Has concentration strength numerator unit	mg	true	Inferred relationship	Some	2
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	Has precise active ingredient	Hyoscine hydrobromide	true	Inferred relationship	Some	1
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	Has BoSS	Papaveretum	true	Inferred relationship	Some	2

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

Reference Sets

Strength reference set

Description inactivation indicator reference set

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3752376017	Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug)	en	Fully specified name	Active	Case insensitive	SNOMED CT core
3752377014	Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection	en	Synonym	Active	Initial character case insensitive	SNOMED CT core
3752378016	Papaveretum 15.4 mg/mL and scopolamine hydrobromide 400 microgram/mL solution for injection	en	Synonym	Active	Initial character case insensitive	SNOMED CT core